Skip to main content

Advertisement

Log in

Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

The basic idea behind this study was to discover the association and prevalence of purinoceptors in hepatitis C virus (HCV) and non-HCV hepatocellular carcinoma (HCC). Immunohistochemistry was performed to study the expression of P2X4 and P2X7 receptors on ex-planted liver tissue samples that were collected from HCC patients. Antibodies specific for the P2X4 and P2X7 receptors were used to target the specific receptors and secondary antibody was used with 3,3′-diaminobenzidine (DAB) detection system to visualize the color change in case of any positive expression There was a substantial increase in P2X4 receptor expression in HCV induced HCC as compared to non-HCV HCC. Surprisingly, there was no increase in the P2X7 receptor expression in both HCV HCC and non-HCV HCC. We conclude that P2X4 receptor expression was significant in the presence of HCV HCC. This may confirms the potential role of P2X4 receptor in the presence of virus in liver pathology. However insignificant expression of P2X7 receptor may avert our attention towards understanding the role of this receptor in pro-inflammatory and immune responses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Saalim M, Resham S, Manzoor S et al (2016) IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma. Tumor Biol 37:105–114

    Article  CAS  Google Scholar 

  2. Bandiera S, Billie Bian C, Hoshida Y et al (2016) Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma. Curr Opin Virol 20:99–105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Manzoor S, Akhtar U, Naseem S et al (2016) Ionotropic purinergic receptors P2X4 and P2X7: proviral or antiviral? an insight into P2X receptor signaling and hepatitis C virus infection. Viral Immunol 29:401–408

    Article  CAS  PubMed  Google Scholar 

  4. Bhatti ABH, Dar FS, Waheed A et al (2016) Hepatocellular carcinoma in Pakistan: National Trends and Global Perspective. Gastroenterol Res Pract 2016:5942306

    Google Scholar 

  5. Ashraf W, Manzoor S, Ashraf J et al (2013) Transcript analysis of P2X receptors in PBMCs of chronic HCV patients: an insight into antiviral treatment response and HCV-induced pathogenesis. Viral Immunol 26:343–350

    Article  CAS  PubMed  Google Scholar 

  6. Di Virgilio F, Adinolfi E (2016) Extracellular purines, purinergic receptors and tumor growth. Oncogene. https://doi.org/10.1038/onc.2016.206

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bodin P, Burnstock G (2001) Purinergic signalling: ATP release. Neurochem Res 26:959–969

    Article  CAS  PubMed  Google Scholar 

  8. Pellegatti P, Raffaghello L, Bianchi G et al (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS ONE 37:e2599

    Article  Google Scholar 

  9. Falzoni S, Donvito G, Di Virgilio F (2013) Detecting adenosine triphosphate in the pericellular space. Interface Focus 3:20120101–20120101

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413–492

    CAS  PubMed  Google Scholar 

  11. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013–1067

    Article  CAS  PubMed  Google Scholar 

  12. Khakh BS, North RA (2006) P2X receptors as cell-surface ATP sensors in health and disease. Nature 442:527–532

    Article  CAS  PubMed  Google Scholar 

  13. Manzoor S, Idrees M, Ashraf J et al (2011) Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a. Virol J 8:431

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. North RA, Surprenant A (2000) Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40:563–580

    Article  CAS  PubMed  Google Scholar 

  15. Gupta GP, Massagué J (2006) Cancer metastasis: building a framework. Cell 127:679–695

    Article  CAS  PubMed  Google Scholar 

  16. Ando T, Imamura H, Suzuki R et al (2012) Visualization and measurement of ATP levels in living cells replicating hepatitis C virus genome RNA. PLoS Pathog 8:e1002561

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Adinolfi E, Melchiorri L, Falzoni S et al (2002) P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99:706–708

    Article  CAS  PubMed  Google Scholar 

  18. Adinolfi E, Cirillo M, Woltersdorf R et al (2010) Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor. FASEB J 24:3393–3404

    Article  CAS  PubMed  Google Scholar 

  19. Jelassi B, Chantôme A, Alcaraz-Pérez F et al (2011) P2 × (7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness. Oncogene 30:2108–2122

    Article  CAS  PubMed  Google Scholar 

  20. Adinolfi E, Raffaghello L, Giuliani AL et al (2012) Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res 72:2957–2969

    Article  CAS  PubMed  Google Scholar 

  21. Jelassi B, Anchelin M, Chamouton J et al (2013) Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors. Carcinogenesis 34:1487–1496

    Article  CAS  PubMed  Google Scholar 

  22. Giuliani AL, Colognesi D, Ricco T et al (2014) Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. PLoS ONE 9:e107224

    Article  PubMed  PubMed Central  Google Scholar 

  23. Qiu Y, Li W-H, Zhang H-Q et al (2014) P2X7 mediates ATP-driven invasiveness in prostate cancer cells. PLoS ONE 9:e114371

    Article  PubMed  PubMed Central  Google Scholar 

  24. Adinolfi E, Capece M, Franceschini A et al (2015) Accelerated tumor progression in mice lacking the ATP receptor P2X7. Cancer Res 75:635–644

    Article  CAS  PubMed  Google Scholar 

  25. Zhou JZ, Riquelme MA, Gao X et al (2015) Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis. Oncogene 34:1831–1842

    Article  CAS  PubMed  Google Scholar 

  26. Xia J, Yu X, Tang L et al (2015) P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway. Oncol Rep 34:103–110

    Article  CAS  PubMed  Google Scholar 

  27. Amoroso F, Capece M, Rotondo A et al (2015) The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma. Oncogene 34:5240–5251

    Article  CAS  PubMed  Google Scholar 

  28. Giannuzzo A, Pedersen SF, Novak I (2015) The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells. Mol Cancer 14:203

    Article  PubMed  PubMed Central  Google Scholar 

  29. Schöfl C, Ponczek M, Mader T et al (1999) Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes. Am J Physiol 276:G164–G172

    PubMed  Google Scholar 

  30. Emmett DS, Feranchak A, Kilic G et al (2008) Characterization of ionotrophic purinergic receptors in hepatocytes. Hepatology 47:698–705

    Article  CAS  PubMed  Google Scholar 

  31. Khalid M, Brisson L, Tariq M et al (2017) Carcinoma-specific expression of P2Y11 receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells. Oncotarget 8(23):37278–37290

    Article  PubMed  PubMed Central  Google Scholar 

  32. Ilahi NE, Anwar S, Noreen M et al (2016) Detection of human papillomavirus-16 DNA in archived clinical samples of breast and lung cancer patients from North Pakistan. J Cancer Res Clin Oncol 142:2497–2502

    Article  CAS  PubMed  Google Scholar 

  33. Balogh J, Victor D, Asham EH et al (2016) Hepatocellular carcinoma: a review. J Hepatocell Carcinoma 3:41–53

    Article  PubMed  PubMed Central  Google Scholar 

  34. Umer M (2016) Hepatitis C virus prevalence and genotype distribution in Pakistan: comprehensive review of recent data. World J Gastroenterol 22:1684

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Dubyak GR (2012) P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell Microbiol 14:1697–1706

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Xiao F, Waldrop SL, Khimji A, Kilic G (2012) Pannexin1 contributes to pathophysiological ATP release in lipoapoptosis induced by saturated free fatty acids in liver cells. Am J Physiol Cell Physiol 303:C1034–C1044

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Fausther M, Gonzales E, Dranoff JA (2012) Role of purinergic P2X receptors in the control of liver homeostasis. Wiley Interdiscip Rev Membr Transp Signal 1:341–348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Schöfl C, Ponczek M, Mader T, Waring M, Benecke H, von zur Mühlen A, Mix H, Cornberg M, Böker KH, Manns MP, Wagner S (1999) Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes. Am J Physiol 276:G164–G172

    PubMed  Google Scholar 

  39. Ferrari D, Pizzirani C, Adinolfi E et al (2006) The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176:3877–3883

    Article  CAS  PubMed  Google Scholar 

  40. Ohsawa K, Irino Y, Nakamura Y et al (2007) Involvement of P2X4 and P2Y 12 receptors in ATP-induced microglial chemotaxis. Glia 55:604–616

    Article  PubMed  Google Scholar 

  41. Lecut C, Frederix K, Johnson DM et al (2009) P2X1 ion channels promote neutrophil chemotaxis through rho kinase activation. J Immunol 183:2801–2809

    Article  CAS  PubMed  Google Scholar 

  42. Abramowski P, Ogrodowczyk C, Martin R, Pongs O (2014) A truncation variant of the cation channel P2RX5 is upregulated during T cell activation. PLoS ONE 9:e104692

    Article  PubMed  PubMed Central  Google Scholar 

  43. Francesco DV, Diego DB, Alba CS et al (2017) The P2X7 receptor in infection and inflammation. J Immun 47:15–31

    Article  Google Scholar 

  44. Taylor JM, Han Z (2010) Purinergic receptor functionality is necessary for infection of human hepatocytes by hepatitis delta virus and hepatitis B virus. PLoS ONE 5:e157

    Google Scholar 

Download references

Acknowledgements

We are thankful to higher education commission and NUST for providing the opportunity to conduct this research work. We are also thankful to Liver transplant unit of Shaikh Zayed Hospital Lahore in coordinating this research work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sobia Manzoor.

Ethics declarations

Conflict of interest

The authors, who contributed for this review paper, do not hold any kind of the conflict of interest.

Research involving human participants and/or animals

This article involved liver biopsy samples from human participants, and does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khalid, M., Manzoor, S., Ahmad, H. et al. Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor. Mol Biol Rep 45, 2625–2630 (2018). https://doi.org/10.1007/s11033-018-4432-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-018-4432-0

Keywords

Navigation